Form 4 for EW Edwards Lifesciences
Accepted 2024-04-08 00:00:00 ET · period of report 2024-04-08 · accession 0001225208-24-005004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-08 | 2024-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +12.5K | 52.3K | +31% | +$459.4K |
| DM | 2024-04-08 | 2024-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $92.33 | -12.5K | 39.8K | -24% | -$1.15M |
| D | 2024-04-08 | 2024-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -12.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-08 | M | A | 12,500 | $36.75 | 52,267.72 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-08 | S | D | 100 | $92.66 | 52,167.72 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-08 | S | D | 12,400 | $92.33 | 39,767.72 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $91.645 to $92.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2024-04-08 | M | D | 12,500 | $0.00 | 0 | D | $36.75 · 2017-06-11 to 2024-05-10 | 12,500 Common Stock |